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Background: Prevention of mother to child transmission of HIV (PMTCT) has been scaled, to more than 90% of
health facilities in Tanzania. Disclosure of HIV results to partners and their participation is encouraged in the
program. This study aimed to determine the prevalence, patterns and predictors of HIV sero-status disclosure to
partners among HIV positive pregnant women in Morogoro municipality, Tanzania.
Methods: A cross sectional study was conducted in March to May 2010 among HIV-positive pregnant women who
were attending for routine antenatal care in primary health care facilities of the municipality and had been tested
for HIV at least one month prior to the study. Questionnaires were used to collect information on possible
predictors of HIV disclosure to partners.
Results: A total of 250 HIV-positive pregnant women were enrolled. Forty one percent (102) had disclosed their
HIV sero-status to their partners. HIV-disclosure to partners was more likely among pregnant women who were
< 25 years old [Adjusted odds ratio (AOR) = 2.2; 95% CI: 1.2–4.1], who knew their HIV status before the current
pregnancy [AOR = 3.7; 95% CI: 1.7–8.3], and discussed with their partner before testing [AOR = 6.9; 95% CI: 2.4–20.1].
Dependency on the partner for food/rent/school fees, led to lower odds of disclosure to partners [AOR = 0.4; 95% CI:
0.1–0.7]. Nine out of ten women reported to have been counseled on importance of disclosure and partner participation.
Conclusions: Six in ten HIV positive pregnant women in this setting had not disclosed their results of the HIV test to
their partners. Empowering pregnant women to have an individualized HIV-disclosure plan, strengthening of the HIV
provider initiated counseling and testing and addressing economic development, may be some of the strategies in
improving HIV disclosure and partner involvement in this setting.
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HIV/AIDS and mother-to-child transmission of HIV
(MTCT) are still major public health problems in sub
Saharan Africa (SSA). SSA has an estimated 68% of the
33 million people living with HIV (PLWHIV) globally,
nearly 90% of pregnant women living with HIV and more
than 90% of HIV infections among children < 15 years old,
globally [1-3]. Strategies to prevent new infections among
the uninfected and prevention of onward vertical or sexual
transmission from HIV infected are therefore vital if the* Correspondence: siamsuya@hotmail.com
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reproduction in any medium, provided the orMDG 6 of halting and reversing the trend of new HIV
infections is to be met by SSA countries in 2015.
Prevention of mother-to-child transmission of HIV
(PMTCT) programs are now available in many low and
middle income countries [4]. Disclosure or sharing of
HIV status with ones sexual partner is encouraged and
is an integral practice both in VCT and PMTCT programs
[2-5], though it is complex and challenging [6-11]. The
Policy in PMTCT programs advocates that all pregnant
women, negative and positive, should be empowered to
disclose their HIV status to their sexual partners through
counselling [2,4,5]. Among HIV-positive pregnant women,
studies has shown that disclosure of HIV status to part-
ners led to increased - acceptance, use and adherence tod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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feeding method selected, increased use of cotrimoxazole
prophylaxis, decreased mortality and increased survival
and follow up among HIV exposed infants [6,12-16].
HIV testing of pregnant women should not only be
the entry point to PMTCT of HIV, but also considered
as an opportunity for prevention of sexual transmission
of HIV. Studies have shown that, a substantial propor-
tion of HIV infected individuals are in stable partnership
with HIV uninfected partners in SSA. The prevalence
of HIV-serodiscordance ranges from 8 -14% in eastern
Africa and 14-27% in southern Africa [17,18]. A large
proportion of new HIV infections in SSA occur among
discordant couples, and disclosure may be one of the
key strategies in reducing HIV transmission [9,17-20].
Studies have shown that disclosure to partners increased
couple dialogue, communication and engagement in pre-
ventive behavior, increased male partner testing, increased
adherence of ARV treatment regimens and improved use of
condoms and other forms of contraception [9,12,14,19,21].
Negative events were fewer than feared earlier when women
disclose their HIV status to their partner [11,12,14,19,22].
The prevalence of HIV sero-status disclosure to sexual
partners has shown to differ between populations. Preva-
lence of disclosure among women attending VCT ranged
between 69% - 86% [7,11,23], 80 -86% among women
attending ARV care and treatment clinics [10,23,24],
and was lowest among pregnant women 16.7% - 46%
[8,9,14,19,21,25]. Disclosure of HIV status is influenced
by a number of factors. It depends on whether the part-
nership is regular rather than casual or an unfamiliar
relationship [23,24,26], a polygamous marriage [14,21],
whether the person being disclosed to has a known
positive status [10,23,24], the number of lifetime sex
partners [25] and fears of abandonment, discrimination,
violence and accusation of infidelity [8,9,11,23,25].
In Tanzania the national PMTCT programme was
introduced in 2004, and by the end of 2011, 91% of
the health facilities with reproductive and child health
(RCH) services were offering PMTCT service [5]. While
systematic data is available on the proportion of pregnant
women who have ever tested for HIV, information on
the pattern of HIV disclosure to partners is not avail-
able, and thus limited in Tanzania [5,27]. Information
on HIV disclosure patterns among pregnant women which
is available was collected before the introduction and scale
up of the national program in 2004 [9,25]. The rates
and reasons affecting disclosure may have changed over
time, and need to be documented so that interventions
to facilitate disclosure between partners are adapted ac-
cordingly. This study aimed to determine the prevalence
of, and predictors of HIV sero-status disclosure to part-
ners among pregnant women in Morogoro Municipality
located in south eastern Tanzania.Methods
Study design and site
This cross sectional study was conducted between March
and May 2010 among HIV positive pregnant women in
Morogoro Municipality, Tanzania. Morogoro Municipality
is one of the six districts of Morogoro region situated in
south eastern Tanzania, about 190 kilometers west of
Dar es Salaam. The district has an approximate popula-
tion of 294,467, with the main economic activities for
about 90% of the population being small scale farming,
keeping livestock, small scale trade and working in the
textile industry [28].
Administratively, the district has one division, 19 wards
and 274 hamlets. At the time of the study, the municipality
had no district hospital, but it had four government health
centres and 12 dispensaries. All of the 16 government
health facilities offered RCH services including routine
antenatal care, child growth monitoring, vaccination,
family planning, HIV counseling and testing for preg-
nant women and offering antiretroviral prophylaxis and
other necessary care for HIV positive women and their
infants.
Attendance for RCH services is high; 98% of women
attend for antenatal care, 78% of children have been fully
vaccinated and 61% deliver with skilled birth attendants,
compared to the national level of 96%, 75% and 50% re-
spectively [27]. The HIV prevalence among adults aged
15–49 years was estimated to be 4.2%; with women having
a higher prevalence (6%) than men (2%) [29]. Ninety one
percent of women and men know where to get tested for
HIV, but only 53% and 37% of women and men of repro-
ductive age respectively, have ever been tested for HIV
in Morogoro.
Population and enrolment procedures
Simple random sampling was used to select six govern-
ment health facilities out of 16 to participate in the study.
Three health centres and three dispensaries participated.
All the HIV positive pregnant women who were attending
the antenatal clinics for routine care during the study
period were eligible to participate. We limited the inclu-
sion to those HIV positive pregnant women who had
undergone counselling and received their HIV test re-
sults at least one month prior to the study.
All the HIV positive women meeting inclusion criteria
were invited to participate. After obtaining informed con-
sent, two trained researchers administered a question-
naire during face to face interviews (a questionnaire can
be accessed at Additional file 1). The collected information
included; socio-demographic information (age, education,
marital status, occupation), socio-economic and household
information (income per month, assets, ownership of
house, and payment for food, fees or rent), sexual and
reproductive health information (parity, birth spacing,
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(transmission and prevention), disclosure to partners
and other relatives and, last perceived benefits and chal-
lenges of disclosure of HIV status. Information on sexual
partners socio-demographic, reproductive and previous
history on HIV- discussion and testing was also collected.Statistical analysis
Descriptive statistics was used to summarize the data.
Bivariate analysis was used to examine associations be-
tween dependent variable (HIV disclosure to partner) and




≥ 25 years 158 (6





None/primary level 193 (7




Currently living with partner/spouse:
Yes 208 (8
No 42 (1
Duration of living together for married/cohabiting (n = 230):
> 2 163 (7
≤ 2 67 (2
Partner’s age (years):
≤ 35 years 129 (5
> 35 years 121 (4
Partner’s education level:
None/primary 145 (5
Secondary and above 105 (4
Partner’s occupation status:
Not employed 161 (6
Employed 89 (3
Age difference between partners (years)
≤ 10 years 209 (8
> 10 years 41 (1be significant at 5% level in the bivariate analyses were
entered in the logistic regression model, to get inde-
pendent predictors of HIV serostatus disclosure to the
partner. Data were analyzed using SPSS statistical soft-
ware, version 16.0 (SPSS, Chicago, IL, USA).Ethical approval
Ethical clearance was obtained from the Ethical Com-
mittee of Kilimanjaro Christian Medical University College,
Tumaini University. Permission to conduct the research
was also obtained from the Medical Officer in charge of
Morogoro Municipality and the heads of the respectiveeristics and HIV-serostatus disclosure to partner/spouse
(%) Disclosed (n = 102) n (%) OR (95% CI) P-value
3.2) 56 (35.4)
6.8) 46 (50.0) 1.8 (1.1-3.1) 0.024
4.0) 50 (37.0)
6.0) 52 (45.2) 1.4 (0.8-2.3) 0.190
7.2) 70 (36.3)
2.8) 32 (56.1) 2.2 (1.2-4.1) 0.007
2.0) 90 (39.1)
.0) 12 (60.9) 2.3 (0.9-5.9) 0.007
3.2) 82 (39.4)
6.8) 20 (47.6) 1.4 (0.7-2.7) 0.324
0.9) 57 (35.0)
9.1) 33 (49.3) 1.81 (1.0-3.2) 0.041
1.6) 51 (39.5)
8.4) 51 (42.1) 1.1 (0.7-1.8) 0.674
8.0) 49 (33.8)
2.0) 53 (50.5) 2.0 (1.2-3.3) 0.008
4.4) 64 (39.8)
5.6) 38 (42.7) 1.1 (0.7-1.9) 0.650
3.6) 77 (36.8)
6.4) 25 (61.0) 2.7 (1.3-5.3) 0.004
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informed consent was obtained from every HIV positive
pregnant woman who agreed to participate in the study.
Results
Socio-demographic characteristics of respondents
A total of 250 HIV positive pregnant women out of 265
participated in the study (response rate 94%). Their age
ranged from 17 to 41 years with a mean (±SD) of 27 (±5.3)
years. A majority of the study participants were married/
cohabiting (92.0%), had primary education (69.0%), were
unemployed (78.8%), dependent on partner for rent/food
or school fees (83%), had ≤ 2 children (79%), with age of
the last born being > 2 years for 98% of the women. In
Tables 1, 2 and 3, the basic socio-demographic, eco-
nomic, and reproductive descriptions of the participants
are depicted.
The majority of the women (80.8%) learned of their
HIV status during their current pregnancy and the time
lapse from knowing their status to interview ranged from
1 to 84 months, (median of 5 months). Few women 15%
(37) discussed with their partners about HIV testing be-
fore taking the test. Of all 250 women, 16% (39) of the
pregnant women’s partners came to the clinics for HIV
counseling and testing and 23% (58) knew their partners
HIV status.
All women reported to have received counseling on in-
fant feeding options and on availability of antiretroviral
drugs (ARVs) to reduce MTCT of HIV. Further, 9 out ofTable 2 Socio-economic factors influencing self disclosure of
Factor Total
Occupation status:
Not employed 197 (78.8)
Employed 53 (21.2)
Income status (TZS)*:
≤ 100,000/= 207 (82.8)
> 100,000/= 43 (17.2)
Accommodation:
Own house/rent house 133 (53.2)
Renting a room 117 (46.8)
Number of household members
≤ 4 171 (68.4)
> 4 79 (31.6)
Number of children <18 years in the household
≤ 2 138 (55.2)
> 2 53 (44.8)
Dependent on partner for food/rent/fees
No 207 (82.8)
Yes 43 (17.2)
*Exchange rate: 1 USD = 1490 TZS in 2010.10 women reported to have received counseling on im-
portance of using condoms, on importance of partner
disclosure and on bringing partner for HIV counseling
and testing, see Table 4.
Prevalence of HIV-serostatus disclosure and patterns
The proportion of women who had disclosed their HIV
serostatus to their partners/spouses was 41% (102/250).
Of the 102 respondents who disclosed their sero-status to
partners, 80% did so within 7 days after getting the results,
while the rest revealed their sero-status sometime later.
In total, 60% (150/250) of the pregnant women had
disclosed their HIV status to either partner or other
family member at the time of interview, see Figure 1.
Among 148 pregnant women who had not disclosed,
43% (64) planned to disclose to their partners in the
future, while 84 women did not plan to disclose at all,
to their sexual partners.
Predictors of HIV self disclosure to partners/spouse
Tables 1, 2 and 3 show the results of bivariate analysis
of predictors for HIV sero-status disclosure to partners.
Women were more likely to disclose their HIV status to
partners if; they were younger than 25 years (p = 0.03),
nulliparous (p < 0.001), had secondary or higher educa-
tion (p = 0.007), had partners who had secondary or
higher education (p = 0.008), had high income (p = 0.01)
and did not depend on their partner for payment of
food/rent/school fees (p < 0.001).HIV- serostatus to partner/spouse (n = 250)
Disclosed (n = 102) N (%) OR (95% CI) P-value
77 (39.1)
25 (47.2) 1.4 (0.8-2.6) 0.288
77 (37.2)
25 (58.1) 2.3 (1.2-4.6) 0.011
60 (45.1)
42 (35.9) 0.7 (0.4-1.1) 0.088
76 (44.4)
26 (32.9) 0.6 (0.4-1.1) 0.085
35 (38.4)
19 (30.2) 0.7 (0.4-1.3) 0.258
74 (35.7)
28 (65.1) 3.4 (1.7-6.7) <0.001
Table 3 Relationship between sexual and reproductive characteristics and HIV serostatus disclosure to partners (n = 250)
Variable Total N (%) Disclosed (n = 102) N (%) OR (95% CI) p-value
Gravida
Multiparous 205 (82.0) 72 (35.1)
Nuliparous 45 (18.0) 30 (66.7) 3.7 (1.9-2.3) <0.001
Living children
≥ 3 53 (21.2) 16 (30.1)
< 3 197 (78.8) 86 (43.7) 1.8 (0.9-3.4) 0.07
Time since knowing HIV status
≤ 12 months 218 (87.2) 79 (36.2)
> 12 moths 32 (12.8) 23 (71.9) 4.5 (2.0-10.2) < 0.001
When diagnosed with HIV
During current pregnancy 208 (83.2) 68 (33.7)
Before current pregnancy 48 (16.8) 34 (70.8) 4.85 (2.4-9.5) < 0.001
Discussed with partner before testing
No 213 (85.2) 70 (32.9)
Yes 37 (14.8) 32 (86.5) 13.1(4.9-35.0) < 0.001
Ever received couple counseling
Yes 41 (16.4) 41 (100)
No 209 (83.6) 61 (29.3) 0.29 (0.24-0.36) < 0.001
Ever used condoms
No 104 (41.6) 31 (29.8)
Yes 146 (58.4) 71 (48.6) 2.2 (1.3-3.8) 0.003
Knowledge on MTCT and PMTCT:
Adequate 178 (71.2) 76 (42.7)
Inadequate 72 (28.8) 26 (36.1) 0.8 (0.4-1.3) 0.34
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used condoms (OR =2.2), and knowledge of woman’s
HIV status before current pregnancy (OR = 4.9) posi-
tively influenced HIV disclosure to the partner. Aware-
ness of partners HIV status and was associated with
HIV disclosure; 98% of pregnant women who knew theirTable 4 Proportion of HIV-positive women counseled on diffe
Variable
Counselor discussed with you about:
Use of ARV to reduce MTCT of HIV
Bringing child for ARV after delivery
Infant feeding options
To make decision on feeding mode before infant is born
Importance of contraceptives after delivery
Importance of condom use during sex with partner
Importance of bring partner for HIV counseling at clinic
On disclosure of your HIV status to partnerpartners HIV status disclosed compared to 23% who
didn’t, p < 0.001.
Perception of benefit of disclosure and counselors
advice also influenced disclosure. Women who perceived
there is benefit were 3 fold more likely to disclose com-
pared to those who didn’t perceive there is benefit ORrent mother-to-child transmission of HIV topics (n = 250)









Figure 1 Distribution of respondents according to whom they
disclosed their HIV-sero status (n = 250).
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counselor did not played a role in disclosure were less
likely to inform their partners about their HIV status
compared to those who appreciated counselors role OR
0.01 (95% CI 0.00 – 0.02).
Religion, occupation of the women or their partner,
partners age, parity, knowledge of PMTCT transmission
or prevention were examined but were not associated
with HIV sero-status disclosure.
In logistic regression analysis (Table 5), women had
increased odds of disclosing their HIV status if; wereTable 5 Logistic regression of predictors for self disclosure of
women (n = 250)
Variable Disclosed (n
Age of participants(years)
≥ 25 years Refe




Age difference between partners (years)
≤ 10 years Refe
> 10 years 2
Dependent on partner for food/rent/fees
No Refe
Yes 0
Discussed with partner before testing
No Refe
Yes 6
When diagnosed with HIV
During current pregnancy Refe
Before current pregnancy 3
† Adjusted for, age education level, income, gravida, duration of living together, tim
partner status and discussing with partner before testing and condom use.aged < 25 years (Adjusted odds ratio AOR = 2.2; 95% CI:
1.2-4.1), had discussed with partners before testing (AOR=
6.9; 95% CI: 2.4-20.1 and had knowledge of their HIV
status before the current pregnancy (AOR = 3.7; 95% CI:
1.7-8.3). Dependency on partner for food/rent/fees de-
creased the odds of disclosure by 60%.
Discussion
This study shows that a relatively low proportion (41%)
of mostly married/cohabiting HIV positive pregnant women
attending antenatal care in Morogoro Municipality had
disclosed their HIV sero-status to their partners. This
prevalence of HIV sero-status disclosure is within the
range of 17% - 46% reported among pregnant women in
Tanzania, Uganda, Kenya, Burkina Faso, and Ivory Coast
[8,9,14,19,21,25]. The time of disclosure in most of the
studies mentioned ranged from 2 months to 18 months
after testing.
There is improvement of HIV disclosure to partners
among pregnant women in Tanzania from 17 -22% in
2001 to 41% in 2010 in the current study [9,25]. How-
ever this proportion is relatively small given the short
period of time before birth where pregnant woman has
to make choices on infant feeding options, prolonged
ARV use for both herself and the infant, and condom
use, all which need partners support [4-6,13,14] and also
given the high prevalence of HIV sero-discordance amongHIV-serostatus to partner/spouse among pregnant













e for HIV diagnosis, age difference between male and female, dependency on
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If the aim is to eliminate HIV transmission to children by
2015, more efforts on sensitization of the community at
large to the benefits of HIV disclosure and couple testing
are required so that women will be able to adhere to the
cascade of PMTCT interventions and prevention of HIV
sexual transmission [2].
Findings from this study showed that there is an associ-
ation between financial dependency and HIV sero-status
disclosure to partners. Participants who depended on their
partners for food, house rent, and school fees were less
likely to disclose their HIV-serostatus to their partner/
spouse, than others. Other markers of low economic sta-
tus such as low income and lower educational level of
the woman or her partner also affected disclosure nega-
tively in bivariate analysis. Previous studies in Tanzania
and South Africa showed that women with low social
economic status or financial dependence on their part-
ner tend to disclose to relatives or others rather than
their own partner [25,26]. Fear of loss of economic sup-
port by the woman is a reality and a major issue in this
set-up where 77% of women had low education, 79%
were not employed and 83% had no income or earned
less than the minimum wage of 100,000 Tanzanian shil-
lings (~ 67 USD) per month according to 2010 exchange
rates. Lack of economic power and dependency to part-
ners not only affect disclosure but have been associated
with poor indicators of maternal and neonate health
such as low levels of skilled birth attendance at delivery,
low attendance for postnatal care, earlier age at sexual
debut and high HIV prevalence [27,29-31].
Women who had discussed HIV testing with their
partners before undertaking the HIV test were seven
times more likely to disclose to their partner than those
who didn’t [6,26,32]. In this study, living with a spouse/
partner did not influence disclosure as also observed by
Antelaman et al., in Dar es Salaam and Makin et al. in
South Africa [25,26]. However it was matters related to
couple communication which was positively associated
with HIV sero-status disclosure; for example condom use
which needs agreement between partners, and awareness
of partners HIV status. A similar association between
partner disclosure and issues related to condom use
and communication were observed in Ethiopia, Uganda
and South Africa [23,24,26,32]. Communication between
partners is vital in enabling a couple to engage in HIV
sexual and perinatal prevention. Couple counseling might
be one way of helping couples to start communication on
HIV and PMTCT issues and needs to be strengthened, as
only 16% of the partners in this study came for counseling
and testing [11,12].
Time of HIV diagnosis significantly influenced HIV dis-
closure to partners. Women who knew their HIV status
for more than 12 months or knew their status beforepregnancy disclosed their HIV status more than others.
It might be due to the fact that they had enough time to
think and accept their status, therefore finding it easier
to disclose, than those who were recently diagnosed and
were still in shock and struggling with the HIV diagnosis
[22]. Disclosure needs time, and other researchers showed
that, rates of HIV sero-status disclosure to partners are
much higher among women tested in VCT or CTC centers
compared to women tested during pregnancy [7,11,22].
There is a need to shift emphasis and empower women
to know their HIV status before pregnancy. Provider
initiated counseling and testing (PITC) needs to be
strengthened in these facilities as it will increase the
number of reproductive age women who know their HIV
status earlier [3].
Our results also point to missed opportunities by the
health system of diagnosing women of reproductive age
earlier for HIV. Most of the participants were multiparous
82% (202/250), and among them 98% had children ≥ to
2 years, (median age of children 3 years, IQR 2–4 years).
These women had multiple contacts with health facilities
when they brought their children for vaccination, child
growth monitoring or when they attended for family plan-
ning services. The need to integrate or strengthen PITC
for HIV at reproductive and child health (RCH) service
delivery points other than antenatal cannot be over em-
phasized, given that multiparous women in this study
were significantly less likely to disclose compared to
nulliparous women.
This study had some limitations. Disclosure of HIV
status is a sensitive topic among HIV positive women
[7,11,26]. These results depended on each woman’s self
report and was not verified by their partner. We cannot
rule out social desirability bias where women reported
what they think the society expects. Secondly, the period
of disclosure of HIV sero-status which was reported for
this work was limited to the duration of the pregnancy,
so our prevalence estimate may be lower compared to
studies which followed women for sometime after delivery
and we could not assess factors that may influence deci-
sion to disclose later such as new partnership or decision
to have other children [9,25,26]. Lastly, because of the
cross sectional nature of the study, we cannot document
whether those who indicated that they have intended to
disclose, actually did so and we also did not address the
outcomes of disclosure. The strength of the study lies in
the high antenatal attendance (98%) by pregnant women
in the region, and with the high study response rate. The
results of this study may be representative of pregnant
women in the area.
Conclusion
In conclusion, disclosure of HIV sero-status has been
identified as an important strategy to reduce vertical and
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is an increase in HIV sero-status disclosure to partners
among pregnant women during pregnancy in Tanzania
(17% to 41%), still 6 out of 10 women enrolled in the study
didn’t disclose to their partners. Factors pertaining to
discussion/communication between partners, economic
dependency, duration of knowledge of HIV status and
age influenced HIV sero-status disclosure.
It is recommended that counselors should be encour-
aged to help women to develop an individualized dis-
closure plan especially targeting older women ≥ 25 years,
multipara women and those who didn’t discuss with
partners before testing. Strengthening and integration of
PITC into other RCH services is recommended. Couple
counseling and broader measures addressing women’s
economic empowerment should be long term goals at
improving HIV disclosure and partner involvement.Additional file
Additional file 1: Questionnaires.
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